Hess, G., Wagner, K., Keller, U., La Rosee, P., Atta, J., Hübel, K., . . . Dreyling, M. (2020). Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma. Hemasphere.
Chicago Style CitationHess, Georg, et al. "Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma." Hemasphere 2020.
Cita MLAHess, Georg, et al. "Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma." Hemasphere 2020.
Atenció: Aquestes cites poden no estar 100% correctes.